Overexpression of RhoV Promotes the Progression and EGFR-TKI Resistance of Lung Adenocarcinoma
Hongjin Chen(Nanjing Medical University), Yongsheng Wang(Sichuan University)
Cited by 31
Related Papers
Dopamine receptor antagonist thioridazine inhibits tumor growth in a murine breast cancer model
|Molecular Medicine Reports|2015|53
Continuous exposure of non-small cell lung cancer cells with wild-type EGFR to an inhibitor of EGFR tyrosine kinase induces chemoresistance by activating STAT3
|International Journal of Oncology|2015|27